OncoDaily IO

The @AACR Immuno-Oncology Research Fellowships Provide $130,000 to Support Clinical Fellows oncodaily.com/opinion/aacr-i… #ImmunoOncology #ImmuneOnc #Immunotherapy #AACR #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Targeted and Immunotherapy Strategies in NSCLC Explored by @myESMO oncodaily.com/blog/esmo-3188… #NSCLC #LungCancer #LCSM #ESMO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Th17 Cells and B Cell Cooperation Drive Durable Tumor Immunity - @Chrystal_Paulos oncodaily.com/blog/chrystal-… @Cancer_Cell @LesinskiLab @Dr_Muranski @WinshipAtEmory @theNCI #NCI #CancerCell #Immunotherapy #ImmuneOnc #TumorImmunity #Cancer #OncoDaily #Medicine #Oncology #MedEd…

Is Adjuvant Immunotherapy Needed after Neoadjuvant Chemoimmunotherapy in Early NSCLC? - @lungoncdoc oncodaily.com/blog/adjuvant-… #Chemoimmunotherapy #NSCLC #LungCancer #LCSM #ImmuneOnc #IO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Promising Results in a Challenging Patient Population with Locally Advanced Unresectable ESCC - Natalia Baran oncodaily.com/insight/natali… #ESCC #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

IASLC - New Insights from Taiki Hakozaki et al. on Gut Microbiota’s Role in NSCLC oncodaily.com/insight/taiki-… @IASLC #Immunotherapy #NSCLC #LungCancer #LCSM #IASLC #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Society for Immunotherapy of Cancer - Congratulations to the 2025 SITC Forward Fund Fellowship Recipients @sitcancer oncodaily.com/blog/society-f… #SITC #Immunotherapy #ImmuneOnc #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Awesome Efficacy of Bispecific Antibody Immunotherapy - @JoshuaBrodyMD oncodaily.com/insight/joshua… @BrianHill_MDPhD #Immunotherapy #IO #ImmuneOnc #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

FLAURA2 Regimen as a New Standart of Care for EGFRm NSCLC - @dplanchard oncodaily.com/science/flaura… #NSCLC #EGFRm #LungCancer #LCSM #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Great to be in Singapore for World Immunotherapy Council 2025 - @BernardAFox oncodaily.com/blog/bernard-a… @theNCI @mysgh #Immunotherapy #ImmuneOnc #IO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Now T Helpers Can Kill? - Sina Zargaran oncodaily.com/insight/sina-z… #Immunotherapy #ImmuneOnc #IO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

🧬 Rare diseases are not rare for the families who live with them. @dinamired | @Amgen | @ghdwpd In this episode, Dr. Paul Burton explores why rare diseases deserve center-stage attention—and how early diagnosis, better policy, and innovative partnerships can change outcomes.…

Early Recurrence in Triple-Negative Breast Cancer After Neoadjuvant Immunotherapy oncodaily.com/oncolibrary/tr… #Immunotherapy #ImmmuneOnc #IO #BreastCancer #BCSM #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Molecular Mechanisms and Therapeutic Potential of Next-Generation Immunotherapeutic Tools - Hung Trinh oncodaily.com/insight/molecu… #Immunotherapy #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Can We Improve Immunotherapy for Hard-To-Treat Pediatric Cancers Like Rhabdomyosarcoma? - @PatrickHwuMD oncodaily.com/science/patric… @Ullrich_Lab @goetheuni @jitcancer #Immunotherapy #ImmuneOnc #PediatricCancer #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Cancer Vaccines: Back to Interferon Therapies? - Miguel Bronchud oncodaily.com/insight/cancer… #Immunotherapy #ImmuneOnc #IO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

The First-Ever National ICE-T Conference Kicks Off in Just 7 Days - @Abdallah81MD oncodaily.com/blog/al-ola-ab… #ImmuneCellEffectorTherapy #Immunotherapy #ImmuneOnc #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

CUE-101 and Pembrolizumab Show Promising Results in HPV-Positive Head and Neck Cancer oncodaily.com/oncolibrary/cu… #Immunotherapy #ImmuneOnc #IO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

SC vs. IV in Immunotherapy - Are We Gaining Time but Losing Equity? - @ADesaiMD @ASCO oncodaily.com/blog/aakash-de… #SC #Immunotherapy #ImmuneOnc #IO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews